Showing Results for
- Academic Journals (4,795)
Search Results
- 4,795
Academic Journals
- 4,795
-
From:Annals of the Rheumatic Diseases (Vol. 62, Issue 4) Peer-ReviewedUnilateral and bilateral involvement of the temporomandibular joint (TMJ) and subsequent growth disturbance of the mandibula is a common feature in juvenile idiopathic arthritis (JIA). (1) The prevalence varies between...
-
From:International Journal of Clinical Rheumatology (Vol. 7, Issue 2) Peer-ReviewedAuthor(s): David R Chen 1 , Philip L Cohen [**] 2 KEYWORDS : adverse effects; anti-CD20; B cells; rheumatoid arthritis; rituximab; treatment efficacy The efficacy of B-cell depletion therapy using anti-CD20...
-
From:Annals of the Rheumatic Diseases (Vol. 62, Issue 4) Peer-ReviewedObjective: To investigate whether patients with acute septic arthritis (SA) diagnosed by positive synovial fluid (SF) culture (Newman grade A) have different clinical and serological features from those with sterile SF...
-
From:The Practitioner (Vol. 254, Issue 1735) Peer-ReviewedWhy is early diagnosis important? How should RA be classified? Why should patients be treated to target? RHEUMATOID ARTHRITIS WAS PREVIOUSLY CONSIDERED A SEVERE SYSTEMIC DISEASE leading to inexorable decline....
-
From:PLoS ONE (Vol. 15, Issue 8) Peer-ReviewedAuthor(s): Bente Appel Esbensen 1,2, Sandra Elkjær Stallknecht 3, Maria Elmegaard Madsen 3,*, Lise Hagelund 4, Trine Pilgaard 4 Introduction In healthy individuals, fatigue can occur temporarily, whereas in people...
-
From:The Journal of Musculoskeletal Medicine (Vol. 17, Issue 3) Peer-ReviewedChen J, Field JA, Glickstein L, et al, Tupper Research Institute, Boston. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia...
-
From:The Journal of Musculoskeletal Medicine (Vol. 28, Issue 5) Peer-ReviewedThe therapeutic options for psoriatic arthritis (PsA) have expanded rapidly and improved patients' pain, function, and quality of life. However, many patients do not respond to the current disease-modifying medications...
-
From:International Journal of Clinical Rheumatology (Vol. 7, Issue 3) Peer-ReviewedAuthor(s): Bradley J Rabquer 1 2 , Alisa E Koch [*] 3 KEYWORDS : adhesion molecules; angiogenesis; biomarker; cadherins; inflammation; integrins; junctional adhesion molecules; rheumatoid arthritis; soluble...
-
From:Physical Therapy (Vol. 75, Issue 10) Peer-ReviewedArthritis commonly affects the hand and wrist in children and may contribute to loss of range of motion and force of the muscles surrounding the involved joints. The purpose of this case report is to describe a physical...
-
From:Annals of the Rheumatic Diseases (Vol. 60, Issue 1) Peer-ReviewedAbstract Objective--To elucidate whether differences in the destructive tissue process in cartilage and bone in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) can be recognised by different release patterns...
-
From:Patient Care (Vol. 35, Issue 16) Peer-ReviewedBradley JD, Katz BR Brandt KD. Severity of knee pain does not predict a better response to an anti-inflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis. J Rheumatol....
-
From:The Journal of Musculoskeletal Medicine (Vol. 18, Issue 12) Peer-ReviewedPredicting success of revision hip arthroplasty in patients with RA What are the best predictors of revision total hip arthroplasty success in patients with rheumatoid arthritis? Patients with rheumatoid arthritis...
-
From:The Journal of Musculoskeletal Medicine (Vol. 20, Issue 2) Peer-ReviewedDoran MF, Crowson CS, Pond et al, Mayo Clinic, Rochester, Minnesota. Frequency of infection in patients with rheurlatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287-2293....
-
From:Annals of the Rheumatic Diseases (Vol. 62, Issue 4) Peer-ReviewedObjective: To assess the relative cost effectiveness of clinical nurse specialist care, inpatient team care, and day patient team care. Methods: Incremental cost effectiveness analysis and cost utility analysis,...
-
From:Annals of the Rheumatic Diseases (Vol. 62, Issue 5) Peer-ReviewedObjectives: To investigate whether anti-Saccharomyces cerevisiae antibodies (ASCA), a marker for Crohn's disease (CD), are present in spondyloarthropathies (SPA) and in the subgroups ankylosing spondylitis (AS),...
-
From:Clinician Reviews (Vol. 16, Issue 8) Peer-ReviewedAbbott Laboratories Abbott Laboratories has received FDA approval of a new delivery system for its drug Humira, which is indicated for the treatment of moderate to severe rheumatoid arthritis and psoriatic arthritis....
-
From:MPR Hematology and Oncology Edition (Vol. 5, Issue 1)ACTEMRA Genentech Rx Interleukin-6 receptor inhibitor. Tocilizumab 20mg/mL; soln for IV infusion after dilution; preservative-free. Indications: Moderately-to severely-active rheumatoid arthritis (RA) in patients...
-
From:Journal of Postgraduate Medicine (Vol. 53, Issue 1) Peer-ReviewedByline: I. Wilson The clinical study of Sert et al .[1] provides limited strength of evidence[2],[3] to support a diagnostic decision to discount toxoplasmosis as a cause of reactive arthritis in seropositive...
-
From:The Journal of Musculoskeletal Medicine (Vol. 17, Issue 1) Peer-ReviewedRao JK, Mihaliak K, Kroenke K, et al, Roudebush Veterans Affairs Medical Center, Indiana University School of Medicine, and Regenstrief Institute for Health Care, Indianapolis. Use of complementary therapies for...
-
From:The Journal of Musculoskeletal Medicine (Vol. 20, Issue 11) Peer-ReviewedABSTRACT: Rheumatoid arthritis (RA) results from an interplay among immunogenetic risk factors, environmental insults, and random modulations of the musculoskeletal and immune systems. RA develops when the synovium...